SEC Form 4 research
| Issuer | Ikena Oncology, Inc. |
|---|---|
| Tickers | IKNA, IMA |
| Reporting owners | 39 |
| Officers and directors | 7 |
| Last public filing | 2026-08-18 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-17 | 2026-08-14 | Grant-Huerta Yanina | A | 39,000 | $0 | Not reported |
| 2026-08-17 | 2026-08-14 | Grant-Huerta Yanina | A | 65,000 | $0 | Not reported |
| 2026-08-17 | 2026-08-14 | Grant-Huerta Yanina | A | 56,000 | $0 | Not reported |
| 2026-08-17 | 2026-08-14 | Yarema Kristin | A | 254,800 | $0 | Not reported |
| 2026-08-17 | 2026-08-14 | Yarema Kristin | A | 250,000 | $0 | Not reported |
| 2026-08-17 | 2026-08-14 | Yarema Kristin | A | 137,200 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.